Pharmacokinetic Properties of Fast-acting Insulin Aspart Administered in Different Subcutaneous Injection Regions: Response to the commentary by Nuggehally R. Srinivas

Clin Drug Investig. 2017 Sep;37(9):885-887. doi: 10.1007/s40261-017-0539-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Blood Glucose
  • Humans
  • Hypoglycemic Agents
  • Injections, Subcutaneous*
  • Insulin
  • Insulin Aspart*

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Insulin Aspart